Here’s what you’ll learn when you read this article: How confocal Raman spectroscopy measures water, lipids, and natural moisturizing factor beneath the skin’s surface rather than relying on visible appearance. What electrical impedance…
Here’s what you’ll learn when you read this article: Controlled insomnia trials show taVNS can improve sleep scores over structured multi-week protocols. Stress physiology markers like HRV and cortisol show mixed, context-dependent results,…
Here’s what you’ll learn when you read this article: Why Sanofi’s investigational acne mRNA vaccine represents a different approach than chronic acne suppression. What Phase 1/2 human testing actually evaluates and what results…
Here’s what you’ll learn when you read this article: What “same-day” neuromodulator results realistically mean and how fast-onset timing differs from final outcomes How short-duration neuromodulators like TrenibotE change commitment, planning, and flexibility…
Here’s what you’ll learn when you read this article: Why the FDA removed prior heart attack and stroke warning language while adding class-wide blood pressure warnings. What the TRAVERSE trial showed about cardiovascular…
Here’s what you’ll learn when you read this article: Why MASH treatment is shifting from single drugs toward combination strategies targeting multiple disease drivers at once What current evidence says about resmetirom plus…
Here’s what you’ll learn when you read this article: Why adding long-acting PYY to GLP-1 therapy showed only modest benefits and meaningful tolerability limits in human studies. How to interpret add-on obesity drug…
Here’s what you’ll learn when you read this article: Why targeting visceral and liver fat differs from appetite-first weight-loss drugs, and what early human data actually show. How INHBE and ALK7 gene-silencing works…
Here’s what you’ll learn when you read this article: How Wegovy tablets work, who qualifies under FDA criteria, and what the evidence shows about weight change and cardiovascular outcomes in eligible adults, using…
Here’s what you’ll learn when you read this article: ActRIIA/B inhibition shows promise in preserving lean muscle during rapid weight loss, unlike GLP-1 drugs alone. New therapies like LAE102 and dual ligand blockers…